Welcome to the official account for AREXVY.
Community Guidelines: https://gsk.to/422iOlQ
Prescribing Information: https://gsk.to/ArexvyPI
Intended for US healthcare professionals only.
Trademarks are owned by or licensed to the GSK group of companies.
©2025 GSK or licensor.
PMUS-RSASMP240122 February 2025
Produced in USA.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://AREXVYhcp.com
- Keywords
- Caliber Healthcare Solutions.
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) Questions
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s website is http://AREXVYhcp.com
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s LinkedIn profile is https://www.linkedin.com/company/arexvyhcp
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s industry is
Pharmaceutical Manufacturing
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s top competitors are
Shingrix (Zoster Vaccine Recombinant, Adjuvanted),
Walgreens,
Pfizer,
Benlysta (Belimumab),
Gsk,
Rsv In Adults,
Strategy In Action,
Johnson & Johnson Medtech,
Caliber Healthcare Solutions,
Abbvie.
Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted)'s categories are Pharmaceutical Manufacturing
